Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating immune complexes in human malignant melanoma

R D'Amelio, B Cooke, J R Hobbs

    Tumori
    |December 31, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Epidemiology of bloodstream infections in a Scottish haemodialysis population with focus on vascular access method.

    The Journal of hospital infection·2021
    Same author

    Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose-the randomized controlled HOMe aFers study.

    BMC medicine·2020
    Same author

    Immunogenicity of meningococcal polysaccharide ACWY vaccine in primary immunized or revaccinated adults.

    Clinical and experimental immunology·2018
    Same author

    Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial.

    European archives of psychiatry and clinical neuroscience·2018
    Same author

    Bone Marrow Transplantation.

    Bristol medico-chirurgical journal (1963)·2017
    Same author

    Evolution of the IgE and IgG repertoire to a comprehensive array of allergen molecules in the first decade of life.

    Allergy·2017
    Same journal

    End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, Italy.

    Tumori·2026
    Same journal

    Quality indicators in identification and care of patients with genetic predisposition to cancer: An AIFET proposal.

    Tumori·2026
    Same journal

    Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion.

    Tumori·2026
    Same journal

    Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLC.

    Tumori·2026
    Same journal

    Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.

    Tumori·2026
    Same journal

    Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

    Tumori·2026
    See all related articles

    Circulating immune complexes (CIC) were low in melanoma patients, appearing only in stage III. No correlation was found between CIC and melanoma-specific protein (MSP), highlighting method-dependent detection of CIC.

    Area of Science:

    • Immunology
    • Oncology
    • Biochemistry

    Background:

    • Circulating immune complexes (CIC) are implicated in various diseases.
    • Malignant melanoma is a significant form of skin cancer.
    • Melanoma-specific protein (MSP) and its antibody have been investigated as potential biomarkers.

    Purpose of the Study:

    • To investigate the presence and levels of CIC in patients with malignant melanoma.
    • To determine the correlation between CIC and melanoma-specific protein (MSP) in these patients.
    • To explore the impact of different laboratory methods on CIC detection.

    Main Methods:

    • Sera from 34 malignant melanoma patients across various clinical stages were analyzed.
    • The C1q solid-phase assay was employed to detect circulating immune complexes (CIC).

    Related Experiment Videos

  • Previous analyses of urine and serum for melanoma-specific protein (MSP) and corresponding antibodies were considered.

    • Main Results:

    • Low levels of CIC were detected, predominantly in stage III of the disease.
    • No positive correlation was observed between the presence of CIC and melanoma-specific protein (MSP).
    • Significant discordance in CIC detection was noted compared to other studies, emphasizing methodological differences.

    Conclusions:

    • CIC levels in malignant melanoma patients are generally low and stage-dependent.
    • The absence of correlation between CIC and MSP suggests distinct roles or detection challenges.
    • Laboratory methods significantly influence the identification and characterization of CIC populations in disease states.